Form 4: Insmed Inc. COO Roger Adsett Sells Shares Under 10b5-1 Trading Plan

Insmed Inc.'s Chief Operating Officer, Roger Adsett, sold 5,945 shares of common stock at a price of $25.09 per share on May 17, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On May 17, 2024, Roger Adsett, the Chief Operating Officer of Insmed Inc., sold 5,945 shares of Insmed's common stock.
• The sale was executed at a price of $25.09 per share.
• Following the transaction, Adsett directly owns 149,275 shares of Insmed Inc.
• The transaction was conducted under a pre-existing 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sentiment is neutral as it simply reports the sale of shares by an executive.

Industry Context

Sales by company executives are a normal part of corporate governance. The use of a 10b5-1 trading plan suggests the executive is selling shares in a pre-planned manner to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by a company executive could have a minor negative impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates this concern.

Key Dates